Brief: Avita Medical Announces CEO Transition
17/10/2025 02:17
Oct 17 (Reuters) - AVITA Medical Inc RCEL.O: AVITA MEDICAL ANNOUNCES CEO TRANSITION BOARD CHAIRMAN CARY VANCE APPOINTED INTERIM CEO CARY VANCE APPOINTED INTERIM CEO JIM CORBETT LEAVES POSITIONS AS CEO Q3 2025 REVENUE EXPECTED TO BE ABOUT $17 MILLION Further company coverage: RCEL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AVITA Medical
See all newsAvita Medical Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Avita Medical Inc Expected To Post A Loss Of 29 Cents A Share: Earnings Preview
Brief: AVITA Medical Q1 EPS USD -0.35
Brief: AVITA Medical Q4 EPS USD -0.38
Brief: Avita Medical Inc - Enters Into Credit Agreement And Guaranty - SEC Filing